| Schedule of Basic and Diluted Net Loss Per Share |
The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(13,498 |
) |
|
$ |
(8,666 |
) |
|
$ |
(27,220 |
) |
|
$ |
(29,447 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding, basic
and diluted |
|
|
54,256,071 |
|
|
|
67,585,121 |
|
|
|
51,029,617 |
|
|
|
67,524,124 |
|
Weighted-average common shares outstanding under the
pre-funded warrant, basic and diluted |
|
|
21,898,000 |
|
|
|
— |
|
|
|
21,173,028 |
|
|
|
— |
|
Weighted-average common shares outstanding, basic
and diluted |
|
|
76,154,071 |
|
|
|
67,585,121 |
|
|
|
72,202,645 |
|
|
|
67,524,124 |
|
Net loss per share, basic and diluted |
|
$ |
(0.18 |
) |
|
$ |
(0.13 |
) |
|
$ |
(0.38 |
) |
|
$ |
(0.44 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders |
The following table sets forth the outstanding potentially dilutive securities, presented as of period-end, that have been excluded in the calculation of diluted net loss per share for the periods presented because to do so would be anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
|
2026 |
|
|
2025 |
|
Stock options to purchase common stock |
|
|
8,471,265 |
|
|
|
5,663,022 |
|
Unvested restricted stock awards and units |
|
|
137,500 |
|
|
|
627,710 |
|
Shares of common stock issuable under Employee
Stock Purchase Plan |
|
|
1,316 |
|
|
|
— |
|
Total potentially dilutive shares |
|
|
8,610,081 |
|
|
|
6,290,732 |
|
|